Comparative Analysis of the QbD Approach in the Pharmaceutical Industry
Introduction. In the development and introduction of medicines into production, the aim of pharmaceutical manufacturers is to comply with the principle of «Quality-by-Design» (QbD). The International Council for Harmonisation (ICH) has created a number of GxP standards, which have become the regulat...
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russian |
| Publicado em: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2019-11-01
|
| coleção: | Разработка и регистрация лекарственных средств |
| Assuntos: | |
| Acesso em linha: | https://www.pharmjournal.ru/jour/article/view/734 |